Statements (69)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:government_agency
|
| gptkbp:collaborates_with |
international regulatory agencies
|
| gptkbp:conducts |
inspections
research on therapeutic goods |
| gptkbp:country |
gptkb:Australia
|
| gptkbp:ensures |
safety of therapeutic goods
efficacy of therapeutic goods quality of therapeutic goods |
| gptkbp:established |
gptkb:1989
|
| gptkbp:full_name |
gptkb:Therapeutic_Goods_Administration
|
| gptkbp:governed_by |
Therapeutic Goods Act 1989
|
| gptkbp:has |
a website
|
| gptkbp:has_role |
public health
|
| gptkbp:headquartered_in |
gptkb:Canberra
|
| https://www.w3.org/2000/01/rdf-schema#label |
TGA Australia
|
| gptkbp:is_a_member_of |
gptkb:International_Coalition_of_Medicines_Regulatory_Authorities
|
| gptkbp:is_involved_in |
gptkb:international_collaboration
risk management policy development stakeholder engagement emergency response planning public consultations public health campaigns post-market surveillance health technology assessment health promotion activities |
| gptkbp:is_part_of |
Australia's health system
|
| gptkbp:issues |
safety alerts
product approvals guidelines for risk assessment recalls of unsafe products guidelines for product registration guidelines for advertising therapeutic goods guidelines for post-market monitoring guidelines for safety reporting |
| gptkbp:monitors |
compliance with regulations
|
| gptkbp:offers |
consultation services
|
| gptkbp:oversees |
gptkb:medical_devices
medicines |
| gptkbp:part_of |
gptkb:health_services
|
| gptkbp:provides |
public information
guidelines for clinical trials advice to government information on clinical trials training for stakeholders support for innovation information on drug interactions information on health risks information on regulatory processes information on product recalls information for consumers information on therapeutic goods standards information on therapeutic goods legislation |
| gptkbp:publishes |
adverse event reports
|
| gptkbp:responsible_for |
monitoring clinical trials
monitoring drug safety monitoring supply chains regulating therapeutic goods monitoring advertising compliance evaluating clinical evidence evaluating safety data licensing manufacturers monitoring adverse events. monitoring therapeutic goods supply |
| gptkbp:supports |
research and development
|
| gptkbp:works_with |
gptkb:healthcare_professionals
|
| gptkbp:bfsParent |
gptkb:Horizon_Therapeutics
gptkb:Benlysta |
| gptkbp:bfsLayer |
5
|